Credit Suisse Ag Celldex Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 51,113 shares of CLDX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,113

Previous 47,998 6.49%

Holding current value

$1.05 Million

Previous $1.9 Million 12.72%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $109,710 - $161,606	3,115 Added 6.49%	51,113 $2.15 Million
Q4 2023 Feb 08, 2024	BUY	$22.61 - $40.65 $162,995 - $293,045	7,209 Added 17.67%	47,998 $1.9 Million
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $256,561 - $377,634	-10,081 Reduced 19.82%	40,789 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $442,718 - $559,500	14,616 Added 40.32%	50,870 $1.73 Million
Q1 2023 May 10, 2023	BUY	$34.78 - $47.43 $84,828 - $115,681	2,439 Added 7.21%	36,254 $1.3 Million
Q4 2022 Feb 13, 2023	SELL	$27.78 - $45.38 $9,472 - $15,474	-341 Reduced 1.0%	33,815 $1.51 Million
Q3 2022 Nov 10, 2022	BUY	$22.7 - $37.57 $96,452 - $159,634	4,249 Added 14.21%	34,156 $960,000
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $19,987 - $36,396	975 Added 3.37%	29,907 $806,000
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $22,858 - $32,517	827 Added 2.94%	28,932 $986,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $73,465 - $115,859	-2,059 Reduced 6.83%	28,105 $1.09 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $108,330 - $209,514	3,742 Added 14.16%	30,164 $1.63 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $466,637 - $796,956	-22,532 Reduced 46.03%	26,422 $883,000
Q1 2021 May 14, 2021	SELL	$16.19 - $29.91 $304,987 - $563,444	-18,838 Reduced 27.79%	48,954 $1.01 Million
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $1.02 Million - $1.54 Million	67,792 New	67,792 $1.19 Million
Q2 2020 Aug 12, 2020	SELL	$1.61 - $13.41 $56,860 - $473,600	-35,317 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.55 - $3.07 $54,741 - $108,423	35,317 New	35,317 $58,000

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $962M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account